- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07550543
PEMF Therapy in Shoulder Tendinopathy
Effect of Pulsed Electromagnetic Field (PEMF) Therapy Delivered Via the Super Inductive System (SIS) Combined With Balneophysiotherapy in Patients With Shoulder Tendinopathies: A Randomized Controlled Trial
The goal of this clinical trial is to evaluate whether pulsed electromagnetic field (PEMF) therapy delivered via the Super Inductive System (SIS), integrated into a multimodal rehabilitation program, improves pain, function, pressure pain threshold, muscle strength, psychological status, and quality of life in adults with shoulder tendinopathies.
The main questions it aims to answer are:
- Does the addition of PEMF (SIS) therapy reduce pain intensity and improve pressure pain threshold compared to standard balneophysiotherapy?
- Does PEMF (SIS) therapy improve shoulder function, muscle strength, psychological status, and quality of life? The study will compare a multimodal rehabilitation program supplemented with PEMF (SIS) therapy to standard balneophysiotherapy to determine whether the addition of PEMF (SIS) provides superior clinical outcomes.
Participants will:
- Undergo a multimodal rehabilitation program including balneophysiotherapy
- Be assigned to receive either standard treatment or treatment supplemented with PEMF (SIS) therapy
- Be evaluated at baseline (admission), immediately after treatment completion (discharge), and at 4 weeks after treatment using validated clinical instruments assessing pain, function, pressure pain threshold, muscle strength, psychological status, depressive symptoms, and quality of life.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Shoulder tendinopathies are a common cause of pain, functional limitation, and reduced quality of life, with a significant impact on daily activities. Their clinical presentation is heterogeneous, involving not only structural and functional impairments but also activity limitations and participation restrictions.
Conservative management remains the first-line approach and typically includes multimodal rehabilitation programs incorporating balneophysiotherapy, exercise therapy, and physical modalities. Although these interventions are widely used and have demonstrated clinical benefits, the optimal combination of therapeutic modalities remains a subject of ongoing research.
Pulsed electromagnetic field (PEMF) therapy delivered via the Super Inductive System (SIS) is a non-invasive intervention with potential analgesic, neuromodulatory, and regenerative effects. However, evidence regarding its additional benefit when integrated into standard multimodal rehabilitation programs for shoulder tendinopathies is still limited.
Given the multifactorial nature of shoulder tendinopathies, a multidimensional assessment approach is required. This study is based on the framework of the International Classification of Functioning, Disability and Health (ICF) and aligned with OMERACT recommendations, allowing a comprehensive evaluation of clinical outcomes across multiple domains.
The aim of this study is to compare the effectiveness of PEMF therapy delivered via SIS, integrated into a multimodal rehabilitation program, with standard balneophysiotherapy in patients with shoulder tendinopathies.
Participants are allocated to either a control group receiving standard treatment or an experimental group receiving the same rehabilitation program supplemented with PEMF (SIS) therapy. Clinical outcomes, including pain intensity, shoulder function, pressure pain threshold, muscle strength, psychological status, depressive symptoms, and quality of life, are assessed at baseline (admission), immediately after treatment completion (discharge), and at 4 weeks after treatment.
This study seeks to determine whether the addition of PEMF (SIS) therapy provides superior outcomes within a multimodal rehabilitation strategy and supports a personalized, multidimensional approach to the management of shoulder tendinopathies.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Alexandra E Ciota, PhD Student
- Phone Number: +40723662300
- Email: alexandra.ciota@365.univ-ovidius.ro
Study Locations
-
-
Techirghiol
-
Constanța, Techirghiol, Romania, 906100
- Recruiting
- Balneal and Rehabilitation Sanatorium of Techirghiol
-
Contact:
- Alexandra E Ciota, PhD Student
- Phone Number: +40723662300
- Email: alexandra.ciota@365.univ-ovidius.ro
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Adults aged between 18 and 70 years.
- Patients with chronic shoulder pain lasting more than 3 months, of non-traumatic origin, persistent despite prior conservative treatment.
- Clinical diagnosis of shoulder tendinopathy and/or subacromial pain syndrome based on medical history and physical examination.
- Presence of shoulder pain and functional limitation confirmed by clinical assessment and baseline functional evaluation (SPADI).
- Ability to comply with the treatment protocol and attend scheduled follow-up assessments.
- Provision of written informed consent prior to participation.
Exclusion Criteria:
- Full-thickness rotator cuff tears with surgical indication.
- Recent major shoulder trauma (within the last 6 months).
- Active systemic inflammatory or rheumatologic diseases.
- Presence of metallic implants in the treatment area or implanted electronic devices (e.g., pacemaker).
- Neurological disorders affecting the upper limb.
- Contraindications to balneotherapy (e.g., severe cardiovascular disease, renal failure, severe dermatological conditions).
- Decompensated chronic diseases at the time of enrollment (cardiovascular, hepatic, renal, respiratory, or neurological).
- Skin lesions at the site of treatment application.
- Pregnancy or breastfeeding.
- Active neoplastic disease.
- Decompensated psychiatric disorders.
- History of hypersensitivity to natural therapeutic factors used in balneotherapy.
- Refusal to participate or inability to provide informed consent.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Balneophysiotherapy plus Nanopulsed Electromagnetic Field Therapy Group
Participants in the experimental group receive a standardized balneophysiotherapy program combined with nanopulsed electromagnetic field therapy (Super Inductive System) applied to the affected shoulder, delivered over 10 treatment days at the Balneal and Rehabilitation Sanatorium Techirghiol, Romania.
|
Nanopulsed electromagnetic field therapy is delivered using the Super Inductive System (SIS) device applied to the affected shoulder.
The intervention is administered daily over a two-week period, with a total of 10 sessions.
Each session lasts approximately 10-15 minutes.
The therapy delivers high-intensity electromagnetic pulses with adjustable frequency and intensity, aiming to reduce pain, stimulate tissue regeneration, and improve functional outcomes.
|
|
Active Comparator: Balneophysiotherapy Control Group
Participants allocated to the control group receive a structured two-week rehabilitation program comprising balneophysiotherapy interventions at the Balneal and Rehabilitation Sanatorium Techirghiol, Romania.
|
The intervention is based on the region's specific natural therapeutic resources and is conducted under continuous medical supervision.
The treatment program includes saline therapeutic baths combined with exercise therapy and applications of sapropelic therapeutic mud, administered daily over a two-week period, five days per week.
In addition, patients receive electrotherapy according to a standardized protocol, including magnetotherapy, interferential current therapy, and therapeutic ultrasound.
The rehabilitation program also incorporates massage therapy and individualized therapeutic exercises.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pain intensity assessed by Visual Analog Scale (VAS)
Time Frame: Baseline, immediately after the 2-week treatment period, and at 1-month follow-up.
|
Pain intensity will be measured using the Visual Analog Scale (VAS).
Participants were asked to rate their current pain intensity by marking a point on a 100-mm horizontal line, where 0 indicates "no pain" and 100 indicates "worst pain imaginable."
The score was recorded in millimeters (mm).
Outcome range and interpretation: Minimum value: 0; Maximum value: 100.
Higher scores indicate worse pain intensity.
|
Baseline, immediately after the 2-week treatment period, and at 1-month follow-up.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Shoulder function assessed by Shoulder Pain and Disability Index (SPADI)
Time Frame: Baseline, immediately after the 2-week treatment period, and at 1-month follow-up.
|
Shoulder pain and disability were assessed using the Shoulder Pain and Disability Index (SPADI), a self-administered questionnaire consisting of two domains: pain (5 items) and disability (8 items).
Each item is scored on a scale from 0 to 10, with higher scores indicating greater pain and functional impairment.
The total SPADI score is expressed as a percentage (0-100%).
|
Baseline, immediately after the 2-week treatment period, and at 1-month follow-up.
|
|
Pressure Pain Threshold (PPT) assessed by digital algometry
Time Frame: Baseline, immediately after the 2-week treatment period, and at 1-month follow-up.
|
Pressure pain threshold will be measured using a digital algometer at standardized anatomical points of the shoulder.
The mean value of repeated measurements will be recorded.
|
Baseline, immediately after the 2-week treatment period, and at 1-month follow-up.
|
|
Range of motion (ROM) assessed by goniometry
Time Frame: Baseline, immediately after the 2-week treatment period, and at 1-month follow-up.
|
Active range of motion of the shoulder (flexion, abduction, external rotation, internal rotation) will be measured using a goniometer.
|
Baseline, immediately after the 2-week treatment period, and at 1-month follow-up.
|
|
Muscle strength assessed by dynamometry
Time Frame: Baseline, immediately after the 2-week treatment period, and at 1-month follow-up.
|
Shoulder muscle strength was assessed using a handheld dynamometer.
Measurements were performed for key shoulder movements, and values were recorded in kilograms.
Higher values indicate greater muscle strength.
|
Baseline, immediately after the 2-week treatment period, and at 1-month follow-up.
|
|
Psychological status assessed by Hospital Anxiety and Depression Scale (HADS)
Time Frame: Baseline, immediately after the 2-week treatment period, and at 1-month follow-up.
|
Psychological status was assessed using the Hospital Anxiety and Depression Scale (HADS), which consists of 14 items divided into two subscales: anxiety (HADS-A) and depression (HADS-D), each containing 7 items.
Participants rated how they had been feeling over the previous week.
Each item is scored on a 4-point Likert scale ranging from 0 to 3. Subscale scores were calculated by summing the relevant item scores and are reported as unitless values.
Outcome range and interpretation: HADS-A (Anxiety): Minimum value: 0; Maximum value: 21.
Higher scores indicate greater anxiety severity.
HADS-D (Depression): Minimum value: 0; Maximum value: 21.
Higher scores indicate greater depressive symptom severity.
|
Baseline, immediately after the 2-week treatment period, and at 1-month follow-up.
|
|
Depression severity assessed by Patient Health Questionnaire-9 (PHQ-9)
Time Frame: Baseline, immediately after the 2-week treatment period, and at 1-month follow-up.
|
Depression severity will be assessed using the Patient Health Questionnaire-9 (PHQ-9), a self-administered questionnaire consisting of 9 items scored from 0 to 3. Total scores range from 0 to 27, with higher scores indicating greater severity of depressive symptoms.
|
Baseline, immediately after the 2-week treatment period, and at 1-month follow-up.
|
|
Quality of life assessed by EQ-5D-5L
Time Frame: Baseline, immediately after the 2-week treatment period, and at 1-month follow-up.
|
Quality of life was assessed using the EQ-5D-5L questionnaire, which evaluates five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression.
Each dimension has five levels of severity.
Higher scores indicate poorer quality of life.
|
Baseline, immediately after the 2-week treatment period, and at 1-month follow-up.
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- AlexandraCiota
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Shoulder Tendinopathy
-
Ministry of Health and Population, EgyptCairo UniversityRecruitingShoulder Rotator Cuff Tendinopathy | Shoulder TendinitisEgypt
-
Ankara City Hospital BilkentNot yet recruitingChronic Shoulder Pain | Rotator Cuff TendinopathyTurkey (Türkiye)
-
University of Medicine and Pharmacy at Ho Chi Minh...RecruitingShoulder Tendinitis | Shoulder TendinopathyVietnam
-
Hacettepe UniversityCompletedShoulder TendinopathyTurkey (Türkiye)
-
Laval UniversityCIRRIS (Center for Interdisciplinary Research in Rehabilitation and Social... and other collaboratorsCompletedShoulder Impingement Syndrome | Shoulder Rotator Cuff TendinopathyCanada
-
Hacettepe UniversityEnrolling by invitationSubacromial Impingement Syndrome | Rotator Cuff Tendinopathy | Rotator Cuff Related Shoulder PainTurkey (Türkiye)
-
Deraya UniversityRecruitingShoulder Pain | Rotator Cuff Tendinopathy | Supraspinatus Tendinopathy | Shoulder DysfunctionEgypt
-
Universidad Católica de ÁvilaCompletedShoulder TendinopathySpain
-
Sword Health, SAUniversity of California, San FranciscoCompletedMusculoskeletal Pain | Chronic Shoulder Pain | Shoulder TendinopathyUnited States
-
Istanbul University - CerrahpasaCompletedShoulder Tendinopathy | Impingement Syndrome | Rotator Cuff Related Shoulder PainTurkey (Türkiye)
Clinical Trials on Nanopulsed Electromagnetic Field Therapy (SIS)
-
Beni-Suef UniversityRecruitingEndometriosis | Pulsed Electromagnetic Therapy | Trans Perineal UltrasoundEgypt
-
Afyonkarahisar Health Sciences UniversityCompletedMusculoskeletal Diseases | Subacromial Impingement Syndrome | Shoulder Pain | Shoulder Injuries and DisordersTurkey
-
Fatih Sultan Mehmet Training and Research HospitalNot yet recruitingLateral Epicondylitis (Tennis Elbow) | MagnetotherapyTurkey (Türkiye)
-
Nanyang Technological UniversityQuantumTX Pte LtdRecruitingAthlete | Sport Performance | Sport RecoverySingapore
-
MTI UniversityNot yet recruitingGait Disorders, Neurologic | Paraparesis | Postural Balance DisordersSaudi Arabia
-
Mayo ClinicRecruitingMyocardial Infarction | Coronary Artery DiseaseUnited States
-
Afyonkarahisar Health Sciences UniversityCompletedMusculoskeletal Diseases | Neck Pain | Chronic Neck Pain | Cervical Disc DiseaseTurkey
-
Mayo ClinicCompleted
-
Faculdade de Ciências Médicas da Santa Casa de...CompletedKnee Osteoarthritis | Knee Arthritis
-
Tel-Aviv Sourasky Medical CenterUnknown